This post was originally published on this site
The use of GLP-1 medications for weight loss has risen dramatically in recent years, and now one government hopes that providing the medications to its workforce will help the economy.
Where in the world? Eli Lilly, a US-based pharmaceutical company, and the British government announced a new deal this month that will provide GLP-1 medications to nearly 250,000 people over the next three years, according to the BBC.
Some 26.2% of the UK’s roughly 67 million people have obesity, according to the UK Office for Health Improvement and Disparities. The pharmaceutical company said that it will invest $364 million to help the